Spanish multi-national Chemo to invest about Rs. 100 Cr in their Hyderabad site

Hyderabad): Spain headquartered Chemo Pharma has announced an investment of over Rs. 100 crores in the creation of the second line in their production area in Hyderabad for the production of pharmaceutical finished dosage forms. In 2021, the company has established additional QC and Stability Labs in their facility in Hyderabad and now is gearing towards commencing commercial operations utilizing upcoming line 2 in production.

The company is also planning to initiate a new Active Pharmaceutical Ingredient and R&D Centre in Hyderabad along with continuing new product development activities in solids and injectables in Genome Valley, Hyderabad.

The announcement was made after Minister KT Rama Rao’s meeting with the leadership of Chemo Group- Dr. Jean Daniel Bonny, R&D Director – Pharmaceuticals Generics Business at World Economic Forum, Davos. Jayesh Ranjan Principal Secretary, Industries and Commerce Dept. and Shakthi M Nagappan, Director Lifesciences, Government of Telangana were also present during the meeting.

Chemo India Formulation started its operations in Genome Valley, Hyderabad in 2018 with the Research, development and manufacturing of pharmaceutical finished dosage forms with specialisation in oral dosage formulations. Since then, the company has witnessed tremendous growth and invested around 170 crores till now along with employment creation of around 270 people.

Dr. Jean briefed the Minister that Chemo India Formulation has been making significant contributions to global operations. The company has taken up around 25 new development projects in solids and 12 new development projects in injectables. Some of the products are getting approvals in the EU region and the entity in Spain is now working towards commercializing some of these products.  A global stability program has also been initiated in Chemo India and the installed capacity is 800 samples per month. Going forward, Chemo India Formulation will work toward strengthening the global stability program and continue to add value to global operations.

Chemo is part of the Spanish multinational Insud Pharma, which has been operating for over 40 years and has a team of 7,000 professionals worldwide. Chemo is a sector leader in the research, development and manufacturing of a broad variety of APIs and a full range of Finished Dosage Forms for both human and veterinary. Globally, Chemo has around 10 manufacturing plants, more than 1100 clients, 10 R&D centers, and more than 100 APIs and finished dosage forms.Minister Mr. K.T Rama Rao said that, “I am delighted that Chemo, a leading pharmaceutical company, is continuing to grow from Hyderabad. This is indeed a testament to the life sciences ecosystem in the city and Genome Valley”. (INN)

Leave a Reply

Your email address will not be published. Required fields are marked *